Company Report

HNX listing delayed

Sao Vang field startup coming in on schedule

Raising target price on new collagen expansion

October exports remain on track

3Q earnings miss as gross margin fails to excite

3Q beats but continued drag from new retailing business

3Q earnings up 209% YoY

3Q earnings miss by 20% on delayed recovery

3Q earnings up by 9% yoy

Significant recovery after the second wave of Covid-19